Werewolf Therapeutics (HOWL) Debt to Equity (2023 - 2025)
Werewolf Therapeutics (HOWL) has disclosed Debt to Equity for 3 consecutive years, with $0.73 as the latest value for Q3 2025.
- Quarterly Debt to Equity rose 155.15% to $0.73 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $0.73 through Sep 2025, up 155.15% year-over-year, with the annual reading at $0.36 for FY2024, 21.27% up from the prior year.
- Debt to Equity for Q3 2025 was $0.73 at Werewolf Therapeutics, up from $0.6 in the prior quarter.
- The five-year high for Debt to Equity was $0.73 in Q3 2025, with the low at $0.24 in Q1 2024.
- Average Debt to Equity over 3 years is $0.38, with a median of $0.33 recorded in 2023.
- The sharpest move saw Debt to Equity dropped 26.86% in 2024, then surged 155.15% in 2025.
- Over 3 years, Debt to Equity stood at $0.29 in 2023, then increased by 21.27% to $0.36 in 2024, then soared by 105.67% to $0.73 in 2025.
- According to Business Quant data, Debt to Equity over the past three periods came in at $0.73, $0.6, and $0.46 for Q3 2025, Q2 2025, and Q1 2025 respectively.